RIL to roll out Covid vaccination drive for employees, families from May 1

Reliance Industries Limited on Friday announced that the company will be rolling out a Covid-19 vaccination programme, 'R-Surakshaa', for its employees and their family members from May 1

Reliance Industries, Mukesh Ambani
Photo: Reuters
ANI
2 min read Last Updated : Apr 23 2021 | 9:20 AM IST

Reliance Industries Limited on Friday announced that the company will be rolling out a COVID-19 vaccination programme for its employees and their family members above the age of 18 years from May 1. The vaccination programme is called 'R-Surakshaa'.

In a letter to RIL employees, the Chairman and Managing Director RIL Mukesh Ambani and Chairperson Reliance Foundation Nita Ambani said that the COVID-19 vaccine is a key weapon again the coronavirus and the company has continued to bear the vaccination cost for all the eligible members.

"In addition, as per the new guidelines of the Government of India, we are pleased to announce that Reliance will roll out its own vaccination programme, R-Surakshaa, across all locations for our employees and eligible family members above the age of 18 years, effective May 1," the letter added.

"We have seamlessly transitioned to 'Work from home' for more than 13 months without disruption to our businesses," he said.

The Reliance Foundation continues to be on the ground addressing the humanitarian challenges, distributing more than 5.5 crore meals and 67 lakhs masks among the needy sections in the society, it added.

Employees were also urged to provide support to the peers, colleagues, and teams.

"Encourage peer-to-peer support. Use the MyVoice platform to encourage sharing experiences, thoughts, and feeling in the safe virtual environment," he said.

The letter stated that those not affected by COVID-19 themselves or within the immediate family should support those who may need to take time off.

"Our priority remains the safety and health of our people. Ensure that you are cascading all the health and safety information to your team. Refer to the R-World portal for all important and updated resources," he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineRILReliance Industries

First Published: Apr 23 2021 | 9:13 AM IST

Next Story